Mesoblast Ltd (MESO) stock
MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.91−0.54 (-4.34%)
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Mesoblast enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Mesoblast's enterprise value was $1.79B on Nov 11, 2026, against $2.10B a year earlier. Over the last 5 years it ranged from $180.28M to $2.19B, with a median of $631.06M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.79B | -18.2% |
| 2025 | Dec 31, 2025 | $2.19B | +8.6% |
| 2024 | Dec 31, 2024 | $2.02B | +841.2% |
| 2023 | Dec 29, 2023 | $214.50M | -49.4% |
| 2022 | Dec 30, 2022 | $424.08M | -32.8% |
| 2021 | Dec 31, 2021 | $631.06M | -33.6% |
| 2020 | Dec 31, 2020 | $951.08M | +18.7% |
| 2019 | Dec 31, 2019 | $801.13M | +94.1% |
| 2018 | Dec 31, 2018 | $412.68M | -1.8% |
| 2017 | Dec 29, 2017 | $420.32M | +36.1% |
| 2016 | Dec 30, 2016 | $308.77M | – |
See a number that looks wrong?